AN2 Therapeutics, Inc. (ANTX)

Latest Insider Confidence Score

2026Q1

49.6
Bearish

Company insider confidence (by quarter)

2022Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Leonard Braden Michael 10% Owner 3,017,432 Jun 16, 2025
Aziz Kabeer Director 2,373,500 Oct 14, 2025
Readnour Robin Shane Director 652,573 Dec 10, 2024
Adjuvant Global Health Technology Fund, L.P. 10% Owner 377,542 Jan 18, 2024
Adjuvant Global Health Technology Fund DE, L.P. 10% Owner 377,542 Jan 18, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2026 Mar 5, 2026 Williams Sarah Joanne Principal Accounting Officer Sell 52.5 -327 -0.49% ✗ $346.6
Feb 20, 2026 Feb 23, 2026 Eizen Joshua M Officer Neutral 90.0 +50,000 31.75% ✗ -
Feb 20, 2026 Feb 23, 2026 Day Lucy CFO Neutral 90.0 +38,000 47.29% ✗ -
Feb 20, 2026 Feb 23, 2026 Williams Sarah Joanne Principal Accounting Officer Neutral 90.0 +48,375 257.31% ✗ -
Feb 20, 2026 Feb 23, 2026 Easom Eric CEO Neutral 85.0 +112,250 7.40% ✗ -
Feb 20, 2026 Feb 23, 2026 Chanda Sanjay Chief Development Officer Neutral 90.0 +38,000 47.02% ✗ -
Feb 20, 2026 Feb 23, 2026 Marks Gilbert Lynn Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2026 Feb 23, 2026 Readnour Robin Shane Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2026 Feb 23, 2026 Wong Stephanie Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2026 Feb 23, 2026 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2026 Feb 23, 2026 Spigelman Melvin K Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2026 Feb 23, 2026 Aziz Kabeer Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2026 Feb 23, 2026 FitzPatrick Margaret M Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2026 Feb 23, 2026 Zakrzewski Joseph S Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2026 Williams Sarah Joanne Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Jan 14, 2026 Aziz Kabeer Director Neutral 60.0 +11,560 0.48% ✗ -
Jan 12, 2026 Jan 14, 2026 Martin Patricia A. Director Neutral 90.0 +3,650 27.54% ✗ -
Jan 12, 2026 Jan 14, 2026 Marks Gilbert Lynn Director Neutral 90.0 +11,560 18.13% ✗ -
Jan 5, 2026 Jan 7, 2026 Day Lucy CFO Sell 47.5 -8,807 -10.46% ✗ $8.9K
Jan 5, 2026 Jan 7, 2026 Prior Stephen David Chief Strategy Officer Sell 47.5 -6,462 -9.86% ✗ $6.5K
Jan 5, 2026 Jan 7, 2026 Chanda Sanjay Chief Development Officer Sell 47.5 -9,251 -10.87% ✗ $9.3K
Jan 5, 2026 Jan 7, 2026 Eizen Joshua M Officer Sell 46.3 -24,854 -14.01% ✗ $25K
Nov 4, 2025 Nov 6, 2025 Eizen Joshua M Officer Sell 47.5 -2,819 -1.56% ✗ $3.2K
Nov 4, 2025 Nov 6, 2025 Prior Stephen David Chief Strategy Officer Sell 47.5 -765 -1.15% ✗ $872.1
Oct 10, 2025 Oct 14, 2025 Marks Gilbert Lynn Director Neutral 90.0 +10,367 19.42% ✗ -
Oct 10, 2025 Oct 14, 2025 Aziz Kabeer Director Neutral 60.0 +10,367 0.43% ✗ -
Oct 10, 2025 Oct 14, 2025 Martin Patricia A. Director Neutral 90.0 +3,274 32.80% ✗ -
Jul 10, 2025 Jul 11, 2025 Aziz Kabeer Director Neutral 60.0 +11,875 0.50% ✗ -
Jul 10, 2025 Jul 11, 2025 Marks Gilbert Lynn Director Neutral 90.0 +11,875 28.61% ✗ -
Jul 10, 2025 Jul 11, 2025 Martin Patricia A. Director Neutral 90.0 +3,750 60.18% ✗ -
May 28, 2025 Jun 16, 2025 Leonard Braden Michael 10% Owner Sell 22.5 -200,000 -6.22% ✗ $218K
Jun 2, 2025 Jun 3, 2025 Easom Eric CEO Buy 68.8 +10,000 0.66% ✗ $10.7K
May 28, 2025 May 30, 2025 Leonard Braden Michael 10% Owner Sell 17.5 -2,532,000 -44.04% ✗ $2.9M
May 28, 2025 May 29, 2025 FitzPatrick Margaret M Director Buy 91.3 +8,610 100.00% ✗ $10.1K
May 22, 2025 May 23, 2025 Readnour Robin Shane Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 23, 2025 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 23, 2025 FitzPatrick Margaret M Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 23, 2025 Zakrzewski Joseph S Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 23, 2025 Spigelman Melvin K Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 23, 2025 Wong Stephanie Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 23, 2025 Marks Gilbert Lynn Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 23, 2025 Aziz Kabeer Director Neutral 52.5 - 0.00% ✗ -
Apr 10, 2025 Apr 11, 2025 Zakrzewski Joseph S Director Neutral 77.5 +10,523 1.95% ✗ -
Apr 10, 2025 Apr 11, 2025 Aziz Kabeer Director Neutral 60.0 +9,705 0.41% ✗ -
Apr 10, 2025 Apr 11, 2025 Martin Patricia A. Director Neutral 90.0 +3,065 96.81% ✗ -
Apr 10, 2025 Apr 11, 2025 Marks Gilbert Lynn Director Neutral 90.0 +9,705 30.52% ✗ -
Feb 26, 2025 Feb 28, 2025 Chanda Sanjay Chief Development Officer Neutral 90.0 +50,250 168.49% ✗ -
Feb 26, 2025 Feb 28, 2025 Day Lucy CFO Neutral 90.0 +46,500 142.33% ✗ -
Feb 26, 2025 Feb 28, 2025 Eizen Joshua M Officer Neutral 90.0 +58,500 50.14% ✗ -
Feb 26, 2025 Feb 28, 2025 Easom Eric CEO Neutral 90.0 +145,250 10.67% ✗ -
Feb 26, 2025 Feb 28, 2025 Prior Stephen David Chief Strategy Officer Neutral 90.0 +28,000 84.05% ✗ -
Jan 3, 2025 Jan 7, 2025 Day Lucy CFO Sell 47.5 -2,957 -8.30% ✗ $4K
Jan 3, 2025 Jan 7, 2025 Chanda Sanjay Chief Development Officer Sell 47.5 -2,957 -9.02% ✗ $4K
Jan 3, 2025 Jan 7, 2025 Prior Stephen David Chief Strategy Officer Sell 47.5 -2,029 -5.74% ✗ $2.7K
Jan 3, 2025 Jan 7, 2025 Eizen Joshua M Officer Sell 46.3 -9,663 -7.65% ✗ $13K
Dec 19, 2024 Dec 23, 2024 Martin Patricia A. Director Neutral 90.0 +3,166 100.00% ✗ -
Dec 19, 2024 Dec 23, 2024 Aziz Kabeer Director Neutral 60.0 +8,972 0.38% ✗ -
Dec 19, 2024 Dec 23, 2024 Marks Gilbert Lynn Director Neutral 90.0 +8,972 39.30% ✗ -
Dec 19, 2024 Dec 23, 2024 Zakrzewski Joseph S Director Neutral 77.5 +9,816 1.85% ✗ -
Dec 19, 2024 Dec 23, 2024 Readnour Robin Shane Director Neutral 67.5 +9,077 0.74% ✗ -
Dec 6, 2024 Dec 10, 2024 Readnour Robin Shane Director Buy 82.5 +60,000 1.67% ✗ $86.7K
Nov 26, 2024 Nov 27, 2024 Readnour Robin Shane Director Buy 87.5 +75,000 3.37% ✗ $105.7K
Nov 27, 2024 Nov 27, 2024 Zakrzewski Joseph S Director Buy 60.0 +2,000 0.38% ✗ $2.8K
Nov 19, 2024 Nov 21, 2024 Readnour Robin Shane Director Buy 95.0 +200,000 10.26% ✗ $213.1K
Nov 18, 2024 Nov 20, 2024 Zakrzewski Joseph S Director Buy 83.8 +25,000 4.96% ✗ $25K
Nov 18, 2024 Nov 18, 2024 Easom Eric CEO Buy 83.8 +50,000 4.48% ✗ $50K
Nov 4, 2024 Nov 5, 2024 Prior Stephen David Chief Strategy Officer Neutral 90.0 +10,125 40.15% ✗ -
Nov 4, 2024 Nov 5, 2024 Eizen Joshua M Officer Neutral 90.0 +31,500 33.22% ✗ -
Nov 5, 2024 Prior Stephen David Chief Strategy Officer Neutral 52.5 - 0.00% ✗ -
Aug 14, 2024 Aug 14, 2024 Leonard Braden Michael 10% Owner Buy 100.0 +1,500,000 35.30% ✗ $1.6M
Aug 9, 2024 Aug 13, 2024 RA CAPITAL MANAGEMENT, L.P. 10% Owner Sell 17.5 -3,525,094 -63.50% ✗ $3.8M
Aug 12, 2024 Leonard Braden Michael 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 10, 2024 Jul 12, 2024 Eizen Joshua M Chief Legal Officer Neutral 90.0 +60,000 172.25% ✗ -
Jun 19, 2024 Jun 21, 2024 Readnour Robin Shane Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2024 Jun 21, 2024 Marks Gilbert Lynn Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2024 Jun 21, 2024 FitzPatrick Margaret M Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2024 Jun 21, 2024 Aziz Kabeer Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2024 Jun 21, 2024 Zakrzewski Joseph S Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2024 Jun 21, 2024 Spigelman Melvin K Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2024 Jun 21, 2024 Martin Patricia A. Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2024 Jun 21, 2024 Wong Stephanie Director Neutral 52.5 - 0.00% ✗ -
Mar 15, 2024 Mar 29, 2024 Eckburg Paul Chief Medical Officer Neutral 90.0 +30,000 140.08% ✗ -
Mar 15, 2024 Mar 29, 2024 Day Lucy CFO Neutral 90.0 +27,500 879.44% ✗ -
Mar 15, 2024 Mar 29, 2024 Eizen Joshua M Chief Legal Officer Neutral 90.0 +30,000 1225.99% ✗ -
Mar 15, 2024 Mar 29, 2024 Krause Kevin Michael Chief Strategy Officer Neutral 90.0 +30,000 1567.40% ✗ -
Mar 15, 2024 Mar 29, 2024 Chanda Sanjay Chief Development Officer Neutral 90.0 +27,500 3741.50% ✗ -
Mar 15, 2024 Mar 29, 2024 Easom Eric CEO Neutral 90.0 +99,000 4647.89% ✗ -
Mar 15, 2024 Mar 18, 2024 Day Lucy CFO Neutral 90.0 +27,500 879.44% ✗ -
Mar 15, 2024 Mar 18, 2024 Eizen Joshua M Chief Legal Officer Neutral 90.0 +30,000 1225.99% ✗ -
Mar 15, 2024 Mar 18, 2024 Krause Kevin Michael Chief Strategy Officer Neutral 90.0 +30,000 1567.40% ✗ -
Mar 15, 2024 Mar 18, 2024 Chanda Sanjay Chief Development Officer Neutral 90.0 +27,500 3741.50% ✗ -
Mar 15, 2024 Mar 18, 2024 Eckburg Paul Chief Medical Officer Neutral 90.0 +30,000 140.08% ✗ -
Mar 15, 2024 Mar 18, 2024 Easom Eric CEO Neutral 85.0 +99,000 8.17% ✗ -
Jan 18, 2024 Jan 19, 2024 Zakrzewski Joseph S Director Sell 17.5 -100,000 -16.55% ✗ $1.9M
Jan 16, 2024 Jan 18, 2024 Aziz Kabeer Director Sell 17.5 -100,000 -4.04% ✗ $2M
Jan 16, 2024 Jan 18, 2024 Adjuvant Global Health Technology Fund, L.P. 10% Owner Sell 17.5 -100,000 -4.04% ✗ $2M
Jan 12, 2024 Jan 17, 2024 Readnour Robin Shane Director Sell 53.8 -1,425 -0.16% ✓ $31.2K
Jan 10, 2024 Jan 12, 2024 Readnour Robin Shane Director Sell 48.8 -3,669 -0.41% ✓ $80.4K
Jan 9, 2024 Jan 11, 2024 Krause Kevin Michael Chief Strategy Officer Sell 10.0 -7,417 -79.49% ✓ $149.4K
Jan 2, 2024 Jan 4, 2024 Krause Kevin Michael Chief Strategy Officer Sell 10.0 -2,583 -57.44% ✓ $52K